Chromium next GEM chip k single cell kit, 48 rxns, chromium next GEM single cell 5' kit V2, 4 rxns, chromium single cell human BCR amplification kit, 16 rxns, chromium single cell human TCR…
Ended Awarded
- Contract number
- 75N95025F00002
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,922
Award facts
- Contract value 100% obligated
- $23,921.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $23,921.70 order is for the procurement of various 10X Genomics products including single cell kits for RNA sequencing, BCR and TCR amplification, and dual index kits. These specialized reagents and consumables support NINDS research efforts related to neurological diseases and disorders. The award is part of a larger $750,000 indefinite delivery contract between 10X Genomics and NINDS for optimization slides, reagents kits, and reagent delivery methods. No set-aside designation was used for this particular order, which has a period of performance through December 31, 2024.
Description
Chromium next GEM chip k single cell kit, 48 rxns, chromium next GEM single cell 5' kit V2, 4 rxns, chromium single cell human BCR amplification kit, 16 rxns, chromium single cell human TCR amplification kit, 16 rxns, dual index kit TT set a, 96
Quick answers
Who was awarded contract 75N95025F00002?
75N95025F00002 was awarded to 10X Genomics, Inc. by National Institute on Drug Abuse (National Institutes of Health) on December 26, 2024.
How much is contract 75N95025F00002 worth?
The government has obligated $23,922 on 75N95025F00002.
Which agency awarded contract 75N95025F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025F00002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95025F00002 an order under another contract?
Yes. 75N95025F00002 is a delivery order under 75N95023D00018, an indefinite delivery contract.
Was contract 75N95025F00002 competed?
The extent of competition for 75N95025F00002 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award